The Clorox Company (NYSE:CLX) Stake Boosted by Cwm LLC

Cwm LLC increased its position in shares of The Clorox Company (NYSE:CLX) by 522.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,430 shares of the company’s stock after purchasing an additional 29,740 shares during the quarter. Cwm LLC’s holdings in Clorox were worth $5,052,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. abrdn plc increased its position in Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after buying an additional 33,135 shares during the period. International Assets Investment Management LLC increased its position in Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. acquired a new stake in Clorox in the third quarter worth $6,605,000. Eagle Rock Investment Company LLC acquired a new stake in Clorox in the fourth quarter worth $2,940,000. Finally, Nordea Investment Management AB increased its position in Clorox by 4.0% in the fourth quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock worth $1,362,000 after buying an additional 364 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

NYSE:CLX opened at $145.98 on Wednesday. The business’s 50-day moving average price is $149.68 and its 200 day moving average price is $142.23. The firm has a market cap of $18.12 billion, a P/E ratio of 231.72, a PEG ratio of 2.27 and a beta of 0.43. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the company posted $0.98 EPS. Clorox’s revenue for the quarter was up 16.0% on a year-over-year basis. As a group, sell-side analysts predict that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.29%. Clorox’s dividend payout ratio (DPR) is 761.92%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CLX. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft lowered their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. The Goldman Sachs Group initiated coverage on Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price target on the stock. DA Davidson reissued a “neutral” rating and set a $162.00 price target on shares of Clorox in a report on Wednesday, April 17th. Finally, Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.